National and Kapodistrian University of Athens
Η επίδραση της εφαρμογής θεραπείας με συνεχή θετική πίεση αεραγωγών επί του επικαρδιακού λιπώδους ιστού και παραγόντων καρδιομεταβολικού κινδύνου, σε πρωτοδιαγνωσμένους ασθενείς με σύνδρομο αποφρακτικής άπνοιας στον ύπνο
Abstract
dc:descriptionAbstract AimThe aim of this study was to assess an independent relationship between obstructive sleep apnea - hypopnea syndrome (OSAHS) sever¬ity, metabolic and vascular markers, and epicardial fat, at base¬line and after 3 months of continuous positive airway pressure (CPAP) therapy.Materials and method Our study group consisted of 48 pa¬tients with suspected OSAHS and no prior history of cardio¬vascular disease or diabetes mellitus. All patients underwent full overnight polysomnography. Thickness of epicardial and visceral adipose tissue, brachial artery flow-mediated dilation (FMD), carotid intima media thickness (cIMT), pulse wave velocity (PWV), HbA1c, homeostatic model assessment of insulin resistance index (HOMA - IR), and lipid profile were measured at baseline and after 3 months of CPAP use in pa¬tients with moderate to severe OSAHS.Results In OSAHS patients (Apnea-hypopnea index (AHI) >15/h, N=28), epicardial fat correlated with fasting glucose (rho=0.406, p=0.04) and HOMA - IR (rho=0.525, p=0.049) but was not associated with visceral fat (rho=0.126, p=0.595). Epicardial adipose tissue (EAT) (p=0.022) increased across AHI severity along with PWV (p=0.045) and carotid intima media thickness (cIMT) (p=0.034) while FMD (p=0.017) de¬creased. Therapy with CPAP reduced both epicardial (p<0.001) and visceral fat (p=0.001). Alterations in epicardial fat across the follow-up were associated with changes in PWV (p=0.026) and HOMA - IR (p=0.037) independently of major confounders.Conclusions Epicardial fat thickness was associated with OSAHS severity and may be an additional marker of cardiovas¬cular risk as well as of future diabetes in these patients. CPAP therapy reduced epicardial fat, suggesting its potentially beneficial role in reducing cardiometabolic risk in OSAHS patients.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- kostopoulos, kostas
- Κωστόπουλος, Κωνσταντίνος
Subjects
dc:subject × 13- Σύνδρομο αποφρακτικής άπνοιας στον ύπνο (ΣΑΥ)
- Επικαρδιακος λιπωδης ιστος
- Καρδιομεταβολικός κινδυνος
- Παχυσαρκία
- CPAP
- Obstructive sleep apnea-hypopnea syndrome
- Epicardial adipose tissue
- Cardiometabolic risk
- Obesity
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/36295